- Company Details
DESCRIPTION provided by applicant Even as the cost and throughput of commercial sequencers has continued to improve over the last years there is still a need to further reduce sequencing costs ...SBIRPhase I2014Department of Health and Human Services National Institutes of Health
DESCRIPTION (provided by applicant): The feasibility of a label-free technology, Millikan Sequencing, will be evaluated for de novo sequencing of mammalian genomes for under 1,000. This novel seque ...SBIRPhase I2010Department of Health and Human Services
CAERUS MOLECULAR DIAGNOSTICS, INC.
LOS ALTOS, CA, 94024-6028
|# of Employees:||2|
|Socially and Economically Disadvantaged:||N|